Home » Topics » BioWorld Science

BioWorld Science
RSS

Galecto Biotech compound is an orally available drug for fibrosis and cancer

Aug. 28, 2018

Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor

Aug. 28, 2018

Hif-1 during high oxygen promotes tumor cell resistance

Aug. 28, 2018

Keeping leptin active

Aug. 28, 2018

Yescarta approved in E.U. for relapsed or refractory DLBCL and PMBCL

Aug. 27, 2018

European Commission approves Kymriah

Aug. 27, 2018

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

Aug. 27, 2018

European Commission approves Vyxeos for two types of high-risk AML

Aug. 27, 2018

Zai Lab discontinues development of ZL-3101 for atopic dermatitis

Aug. 27, 2018

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

Aug. 27, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...